Novo Nordisk A/S (NNO2) Short Interest
WBAG • NNO2 • DK0062498333
As of Oct 28, 2026, ORTEX estimated 0% of free float sold short, 124 days to cover, cost to borrow 1.56%. Sign up for live short interest data.
WBAG • NNO2 • DK0062498333
As of Oct 28, 2026, ORTEX estimated 0% of free float sold short, 124 days to cover, cost to borrow 1.56%. Sign up for live short interest data.
This page tracks how heavily Novo Nordisk A/S (WBAG:NNO2) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Novo Nordisk A/S (WBAG: NNO2) has a market capitalization of $179.56B. Last close €36.59 (as of 2026-11-12); 52-week range €30.01 to €55.08. ORTEX data as of 2026-10-28: short interest was 0.02% of free float, 124 days to cover and the average cost to borrow was 1.56%. Sign up for live short interest data.